Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Rating of "Buy" by Brokerages

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) have earned a consensus rating of "Buy" from the fourteen analysts that are covering the firm, MarketBeat reports. Fourteen analysts have rated the stock with a buy rating.
Read more...